NJ S3452Introducedas of 2026-02-09
Establishes protection from adverse employment action for authorized medical cannabis patients.
Plain-English summary
What happened: A New Jersey Senate bill establishing employment protections for authorized medical cannabis patients against adverse employer actions has been introduced and referred to the Senate Labor Committee.
Why it matters: If enacted, the bill would limit employers' ability to take adverse action based on an employee's authorized medical cannabis use, affecting workforce policies across all cannabis-touching businesses.
Affects: retailers and cultivators and labs and patients
LATEST ACTION: Introduced in the Senate, Referred to Senate Labor Committee
READ THE FULL BILL TEXT →Follow New Jersey cannabis bills for free. One plain-English email a week with every bill that moved, including this one.
Get the free digestMore New Jersey cannabis bills
S4635Aligns State restrictions on sale of hemp products and intoxicating hemp beverages with federal law.Passed ChamberA5649Prohibits law enforcement officers, first responders, CDL drivers, or persons who operate heavy equipment from engaging in recreational use of cannabis items.IntroducedA5683Allows Cannabis Regulatory Commission to award competitive grants from Social Equity Excise Fee proceeds.IntroducedA5604Aligns State restrictions on sale of hemp products and intoxicating hemp beverages with federal law.IntroducedS4726Allows Cannabis Regulatory Commission to award competitive grants from Social Equity Excise Fee proceeds.IntroducedS4685Prohibits law enforcement officers, first responders, CDL drivers, or persons who operate heavy equipment from engaging in recreational use of cannabis items.IntroducedA5476Requires training for employees in certain settings to recognize and respond to indications of intoxication in children from consumption of cannabis item.IntroducedA5463Requires cannabis retailer to display notice of risks of high potency cannabis.Introduced
ALL NEW JERSEYCANNABIS LAWS & BILLS →Legislative data via LegiScan, licensed under CC BY 4.0. Summaries and categorization by CannaSignal. Regulatory information, not legal advice.